TGFB1 and colorectal carcinoma: To confirm their relevance to CRC, we used small-molecule inhibitors to inhibit the Wnt (XAV939 and IWP-2) or TGF-β (SB-431542) signaling in HT115 cells, which led to significant reduction in cell viability (Figure 1c).